Business registries · firm from USPTO records

KemPharm, Inc.

USPTO only Derived from USPTO records only (patent assignees and trademark owners); FURP found no state registration, Form D, Form ADV, nonprofit, SEC or lobbying record with this name and place.

Place
2500 Crosspark Rd., Suite E126, Coralville, IA
Entity type
Corporation
State of organization
DE (as the owner states it in trademark filings)
Patents
22 granted 2006-06-16 to 2018-12-05
Trademarks
37, 8 live
Record
EXACT high confidence: USPTO records only: patent assignee and trademark owner with the same name (legal endings aside) and place
Source
USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place

Patents

PatentTitleGrantedSource
US 11505537Compositions comprising methylphenidate-prodrugs, processes of making and using the same2022-11-22PVGPATDIS, file of 2026-04-10
US 11234975Levorphanol prodrugs and processes for making and using them2022-02-01PVGPATDIS, file of 2026-04-10
US 11214544Dextrorphan prodrugs and processes for making and using them2022-01-04PVGPATDIS, file of 2026-04-10
US 11174229D-amphetamine compounds, compositions, and processes for making and using the same2021-11-16PVGPATDIS, file of 2026-04-10
US 11136295D-amphetamine compounds, compositions, and processes for making and using the same2021-10-05PVGPATDIS, file of 2026-04-10
US 11021460Compositions comprising methylphenidate-prodrugs, processes of making and using the same2021-06-01PVGPATDIS, file of 2026-04-10
US 11021459Compositions comprising methylphenidate-prodrugs, processes of making and using the same2021-06-01PVGPATDIS, file of 2026-04-10
US 10954213Compositions comprising methylphenidate-prodrugs, processes of making and using the same2021-03-23PVGPATDIS, file of 2026-04-10
US 10954212Compositions comprising methylphenidate-prodrugs, processes of making and using the same2021-03-23PVGPATDIS, file of 2026-04-10
US 10912744Therapeutic formulation for reduced drug side effects2021-02-09PVGPATDIS, file of 2026-04-10
US 10870654Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same2020-12-22PVGPATDIS, file of 2026-04-10
US 10858341Compositions comprising methylphenidate-prodrugs, processes of making and using the same2020-12-08PVGPATDIS, file of 2026-04-10
US 10759778Methylphenidate-prodrugs, processes of making and using the same2020-09-01PVGPATDIS, file of 2026-04-10
US 10758528Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods of making and use thereof2020-09-01PVGPATDIS, file of 2026-04-10
US 10654863Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof2020-05-19PVGPATDIS, file of 2026-04-10
US 10584113Methylphenidate-prodrugs, processes of making and using the same2020-03-10PVGPATDIS, file of 2026-04-10
US 10584112Methylphenidate-prodrugs, processes of making and using the same2020-03-10PVGPATDIS, file of 2026-04-10
US 10577376Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof2020-03-03PVGPATDIS, file of 2026-04-10
US 10544153Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof2020-01-28PVGPATDIS, file of 2026-04-10
US 10463660Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods of making and use thereof2019-11-05PVGPATDIS, file of 2026-04-10
US 10463633Therapeutic formulation for reduced drug side effects2019-11-05PVGPATDIS, file of 2026-04-10
US 10441661Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof2019-10-15PVGPATDIS, file of 2026-04-10
US 10358452Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof2019-07-23PVGPATDIS, file of 2026-04-10
US 10351574Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same2019-07-16PVGPATDIS, file of 2026-04-10
US 10351573Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof2019-07-16PVGPATDIS, file of 2026-04-10

All patents of this assignee

Trademarks

MarkSerialFiledStatusClassesSource
APADAZ882173422018-12-05Abandoned005TRCFECO2, file of 2024-03-27
APADAZ882173322018-12-05Abandoned005TRCFECO2, file of 2024-03-27
APADAZ882173232018-12-05Abandoned005TRCFECO2, file of 2024-03-27
APADAZ882173162018-12-05Abandoned005TRCFECO2, file of 2024-03-27
ZYNESTOR882057712018-11-26Abandoned005TRCFECO2, file of 2024-03-27
REMFIUS882057672018-11-26Abandoned005TRCFECO2, file of 2024-03-27
MYTENZAL882057622018-11-26Abandoned005TRCFECO2, file of 2024-03-27
NEUBINTIC882057562018-11-26Abandoned005TRCFECO2, file of 2024-03-27
MYONDEY882057492018-11-26Abandoned005TRCFECO2, file of 2024-03-27
LANDEXIS882057362018-11-26Abandoned005TRCFECO2, file of 2024-03-27
CYNSTIOR882057322018-11-26Abandoned005TRCFECO2, file of 2024-03-27
CENSTIDA882057272018-11-26Abandoned005TRCFECO2, file of 2024-03-27
XLANDEXYS882057172018-11-26Abandoned005TRCFECO2, file of 2024-03-27
ATTIENZ881920162018-11-13Abandoned005TRCFECO2, file of 2024-03-27
(design)881778762018-11-01Registered005TRTDXFAP, file of 2026-04-01
(design)881778692018-11-01Registered005TRTDXFAP, file of 2026-04-01
EPYON THERAPEUTICS880458902018-07-20Abandoned042TRCFECO2, file of 2024-03-27
EPYON880203042018-06-29Abandoned042TRCFECO2, file of 2024-03-27
KEMPHARM INC879808582018-02-15Registration cancelled005, 042TRTDXFAP, file of 2026-02-04
KEMPHARM INC879808382018-02-15Registration cancelled042TRTDXFAP, file of 2026-08-19
KEMPHARM879807302018-02-15Registration cancelled005TRTDXFAP, file of 2026-01-28
KEMPHARM877991382018-02-15Abandoned005TRCFECO2, file of 2024-03-27
KEMPHARM INC877991272018-02-15Abandoned005TRCFECO2, file of 2024-03-27
KEMPHARM INC877991232018-02-15Abandoned005TRCFECO2, file of 2024-03-27
SXR877990992018-02-15Abandoned042TRCFECO2, file of 2024-03-27

The newest 25 of 37. All marks of this owner

No other firm on file at the same street address.

Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.